Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Income Tax: $121M in Q3 2026, down 54.5% from a year earlier.
Latest, Q3 2026
121
Period ended Sep 30, 2026
Change on a year earlier
-54.5%
266 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
32
Documents cited below
Where the Q3 2026 figure comes from
“|| Income taxes | – 121 | – 266”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Postgres DB + Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Income Tax ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-tax
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.